Medpace Holdings (MEDP) Stock Statistics & Valuation Metrics

Medpace Holdings has a market cap or net worth of $12.29B. The enterprise value is $13.81B.

Medpace Holdings has 28,093,025 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medpace Holdings’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 37.24%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Medpace Holdings had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.

In the last 12 months, operating cash flow was 614.10M and capital expenditures -18.18M, giving a free cash flow of 595.92M billion.

Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Medpace Holdings upcoming earnings date is Oct 27, 2025, After Close (Confirmed).

Medpace Holdings as a current ratio of 0.93, with Debt / Equity ratio of 72.50%

In the past 12 months, Medpace Holdings has paid 71.54M in taxes.

Medpace Holdings EV to EBITDA ratio is 20.51, with an EV/FCF ratio of 17.06.

Medpace Holdings has $46.33M in cash and marketable securities with $124.95M in debt, giving a net cash position of $78.62M billion.

Gross margin is 31.62%, with operating margin of 21.19%, and net profit margin of 19.17%.

The average price target for Medpace Holdings is $410.88, which is 11.43% higher than the current price. The consensus rating is Hold